BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grace BS, Clayton P, McDonald SP. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy. Nephrology (Carlton) 2012;17:76-84. [PMID: 21854505 DOI: 10.1111/j.1440-1797.2011.01512.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 37] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Pippias M, Jager KJ, Kramer A, Leivestad T, Sánchez MB, Caskey FJ, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS. The changing trends and outcomes in renal replacement therapy: data from the ERA-EDTA Registry. Nephrol Dial Transplant 2016;31:831-41. [PMID: 26361801 DOI: 10.1093/ndt/gfv327] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 11.9] [Reference Citation Analysis]
2 Baban B, Liu JY, Mozaffari MS. Endoplasmic reticulum stress response and inflammatory cytokines in type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase and programmed death-1. Experimental and Molecular Pathology 2013;94:343-51. [DOI: 10.1016/j.yexmp.2012.11.004] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.3] [Reference Citation Analysis]
3 Wang Z, Hoy WE. Diabetes and Lifetime Risk of ESRD in High-Risk Remote-Dwelling Australian Aboriginal People: A 20-Year Cohort Study. American Journal of Kidney Diseases 2013;62:845-6. [DOI: 10.1053/j.ajkd.2013.05.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
4 Ge C, Xu M, Qin Y, Gu T, Lou D, Li Q, Hu L, Nie X, Wang M, Tan J. Fisetin supplementation prevents high fat diet-induced diabetic nephropathy by repressing insulin resistance and RIP3-regulated inflammation. Food Funct 2019;10:2970-85. [DOI: 10.1039/c8fo01653d] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Mckercher C, Chan HW, Clayton PA, Mcdonald S, Jose MD. Dialysis outcomes of elderly Indigenous and non-Indigenous Australians: Dialysis outcomes of elderly Australians. Nephrology 2014;19:610-6. [DOI: 10.1111/nep.12317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
6 Chen PW, Hsu LW, Chang HY, Huang TC, Yu JR, Liao HY, Lee CH, Liu PY. Elevated Platelet Galectin-3 and Rho-Associated Protein Kinase Activity Are Associated with Hemodialysis Arteriovenous Shunt Dysfunction among Subjects with Diabetes Mellitus. Biomed Res Int 2019;2019:8952414. [PMID: 31080833 DOI: 10.1155/2019/8952414] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Couchoud C, Villar E. End-stage renal disease epidemic in diabetics: is there light at the end of the tunnel? Nephrology Dialysis Transplantation 2013;28:1073-6. [DOI: 10.1093/ndt/gfs559] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
8 van Dijk PR, Kramer A, Logtenberg SJ, Hoitsma AJ, Kleefstra N, Jager KJ, Bilo HJ. Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3. BMJ Open 2015;5:e005624. [PMID: 25636789 DOI: 10.1136/bmjopen-2014-005624] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
9 Dorajoo SR, Ng JSL, Goh JHF, Lim SC, Yap CW, Chan A, Lee JYC. HbA1c variability in type 2 diabetes is associated with the occurrence of new-onset albuminuria within three years. Diabetes Res Clin Pract 2017;128:32-9. [PMID: 28432897 DOI: 10.1016/j.diabres.2017.02.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
10 Grace BS, Clayton PA, Cass A, McDonald SP. Transplantation rates for living- but not deceased-donor kidneys vary with socioeconomic status in Australia. Kidney Int 2013;83:138-45. [PMID: 22895516 DOI: 10.1038/ki.2012.304] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
11 Zimbudzi E, Lo C, Ranasinha S, Kerr PG, Usherwood T, Cass A, Fulcher GR, Zoungas S. Self-management in patients with diabetes and chronic kidney disease is associated with incremental benefit in HRQOL. J Diabetes Complications 2017;31:427-32. [PMID: 27914731 DOI: 10.1016/j.jdiacomp.2016.10.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
12 Reutens AT. Epidemiology of diabetic kidney disease. Med Clin North Am. 2013;97:1-18. [PMID: 23290726 DOI: 10.1016/j.mcna.2012.10.001] [Cited by in Crossref: 116] [Cited by in F6Publishing: 98] [Article Influence: 12.9] [Reference Citation Analysis]
13 Koye DN, Magliano DJ, Reid CM, Pavkov ME, Chadban SJ, McDonald SP, Polkinghorne KR, White S, Paul C, Shaw JE. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013. Am J Kidney Dis 2019;73:300-8. [PMID: 30579709 DOI: 10.1053/j.ajkd.2018.10.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
14 Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol 2016;12:73-81. [DOI: 10.1038/nrneph.2015.173] [Cited by in Crossref: 213] [Cited by in F6Publishing: 194] [Article Influence: 30.4] [Reference Citation Analysis]
15 McKercher C, Sanderson K, Jose MD. Psychosocial factors in people with chronic kidney disease prior to renal replacement therapy. Nephrology (Carlton) 2013;18:585-91. [PMID: 23876102 DOI: 10.1111/nep.12138] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
16 Beig JY, Semple DJ. Changing ethnic and clinical trends and factors associated with successful home haemodialysis at Auckland District Health Board. Intern Med J 2019;49:1425-35. [PMID: 30719826 DOI: 10.1111/imj.14240] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Huria T, Palmer S, Beckert L, Williman J, Pitama S. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis. Int J Equity Health 2018;17:27. [PMID: 29458366 DOI: 10.1186/s12939-018-0737-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
18 White S, Chadban S. Diabetic kidney disease in Australia: current burden and future projections. Nephrology (Carlton) 2014;19:450-8. [PMID: 24888506 DOI: 10.1111/nep.12281] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
19 Kazawa K, Takeshita Y, Yorioka N, Moriyama M. Efficacy of a disease management program focused on acquisition of self-management skills in pre-dialysis patients with diabetic nephropathy: 24 months follow-up. J Nephrol 2015;28:329-38. [DOI: 10.1007/s40620-014-0144-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
20 De Meyer V, Abramowicz D, De Meester J, Collart F, Bosmans JL, Cools W, Wissing KM. Variability in the incidence of renal replacement therapy over time in Western industrialized countries: A retrospective registry analysis. PLoS One 2020;15:e0235004. [PMID: 32584849 DOI: 10.1371/journal.pone.0235004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Jesudason S, Grace BS, McDonald SP. Pregnancy outcomes according to dialysis commencing before or after conception in women with ESRD. Clin J Am Soc Nephrol. 2014;9:143-149. [PMID: 24235285 DOI: 10.2215/cjn.03560413] [Cited by in Crossref: 81] [Cited by in F6Publishing: 31] [Article Influence: 9.0] [Reference Citation Analysis]
22 Nakamura E, Sofue T, Kunisho Y, Onishi K, Yamaguchi K, Ibuki E, Taoka R, Ueda N, Sugimoto M, Minamino T. Transplant Prognosis in Kidney Transplant Recipients with Diabetes under Mycophenolic Acid-Focused Therapeutic Drug Monitoring. J Pers Med 2021;11:1224. [PMID: 34834579 DOI: 10.3390/jpm11111224] [Reference Citation Analysis]
23 Choi JY, Jang HM, Park J, Kim YS, Kang SW, Yang CW, Kim NH, Cho JH, Park SH, Kim CD, Kim YL; Clinical Research Center for End Stage Renal Disease (CRC for ESRD) Investigators. Survival advantage of peritoneal dialysis relative to hemodialysis in the early period of incident dialysis patients: a nationwide prospective propensity-matched study in Korea. PLoS One. 2013;8:e84257. [PMID: 24386357 DOI: 10.1371/journal.pone.0084257] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
24 Zrim S, Furlong T, Grace BS, Meade A. Body mass index and postoperative complications in kidney transplant recipients. Nephrology (Carlton) 2012;17:582-7. [PMID: 22624682 DOI: 10.1111/j.1440-1797.2012.01621.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
25 Petrak F, Baumeister H, Skinner TC, Brown A, Holt RIG. Depression and diabetes: treatment and health-care delivery. Lancet Diabetes Endocrinol 2015;3:472-85. [PMID: 25995125 DOI: 10.1016/S2213-8587(15)00045-5] [Cited by in Crossref: 93] [Cited by in F6Publishing: 22] [Article Influence: 13.3] [Reference Citation Analysis]
26 Devetzis V, Daryadel A, Roumeliotis S, Theodoridis M, Wagner CA, Hettwer S, Huynh-Do U, Ploumis P, Arampatzis S. C-Terminal Fragment of Agrin (CAF): A Novel Marker for Progression of Kidney Disease in Type 2 Diabetics. PLoS One 2015;10:e0143524. [PMID: 26630274 DOI: 10.1371/journal.pone.0143524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
27 Grace BS, Clayton P, Cass A, Mcdonald SP. Socio-economic status and incidence of renal replacement therapy: a registry study of Australian patients. Nephrology Dialysis Transplantation 2012;27:4173-80. [DOI: 10.1093/ndt/gfs361] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
28 Yu ZY, Chen LS, Zhang LC, Zhou TB. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy. Nephrology (Carlton) 2012;17:480-7. [PMID: 22385293 DOI: 10.1111/j.1440-1797.2012.01592.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
29 Brimble KS, Mehrotra R, Tonelli M, Hawley CM, Castledine C, McDonald SP, Levidiotis V, Gangji AS, Treleaven DJ, Margetts PJ, Walsh M. Estimated GFR reporting influences recommendations for dialysis initiation. J Am Soc Nephrol 2013;24:1737-42. [PMID: 23990673 DOI: 10.1681/ASN.2013010035] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 McKercher C, Jose MD, Grace B, Clayton PA, Walter M. Gender differences in the dialysis treatment of Indigenous and non-Indigenous Australians. Aust N Z J Public Health. 2017;41:15-20. [PMID: 27960225 DOI: 10.1111/1753-6405.12621] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
31 Assogba FG, Couchoud C, Hannedouche T, Villar E, Frimat L, Fagot-Campagna A, Jacquelinet C, Stengel B; French Renal Epidemiology and Information Network Registry. Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011. Diabetologia 2014;57:718-28. [PMID: 24496924 DOI: 10.1007/s00125-014-3160-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
32 Martínez-Castelao A, Górriz JL, Ortiz A, Navarro-González JF. ERBP guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher. Metformin for all? Nefrologia 2017;37:567-71. [PMID: 28669489 DOI: 10.1016/j.nefro.2017.06.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Zhao Y, Yang J, Zhang L, Li Z, Yang Y, Tang Y, Fu P. Association between TNF-α -308G/A polymorphism and diabetic nephropathy risk: a meta-analysis. Int Urol Nephrol. 2013;45:1653-1659. [PMID: 23793620 DOI: 10.1371/journal.pone.0002546] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.8] [Reference Citation Analysis]
34 Robles NR, Villa J, Gallego RH. Non-Proteinuric Diabetic Nephropathy. J Clin Med. 2015;4:1761-1773. [PMID: 26371050 DOI: 10.3390/jcm4091761] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
35 Hill K, Ward P, Grace BS, Gleadle J. Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand. BMC Public Health 2017;17:802. [PMID: 29020957 DOI: 10.1186/s12889-017-4807-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
36 Tan J, Manley P, Gamble G, Collins J, Bagg W, Hotu C, Braatvedt G; DEFEND investigators. Long-term effectiveness of a community-based model of care in Māori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4-year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) study. Intern Med J 2015;45:843-9. [PMID: 25872126 DOI: 10.1111/imj.12788] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
37 Thomas MC. Epigenetic Mechanisms in Diabetic Kidney Disease. Curr Diab Rep 2016;16:31. [PMID: 26908156 DOI: 10.1007/s11892-016-0723-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
38 Sun XY, Qin HJ, Zhang Z, Xu Y, Yang XC, Zhao DM, Li XN, Sun LK. Valproate attenuates diabetic nephropathy through inhibition of endoplasmic reticulum stress‑induced apoptosis. Mol Med Rep 2016;13:661-8. [PMID: 26647757 DOI: 10.3892/mmr.2015.4580] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
39 Martínez-Castelao A, Navarro-González JF, Górriz JL, de Alvaro F. The Concept and the Epidemiology of Diabetic Nephropathy Have Changed in Recent Years. J Clin Med 2015;4:1207-16. [PMID: 26239554 DOI: 10.3390/jcm4061207] [Cited by in Crossref: 61] [Cited by in F6Publishing: 49] [Article Influence: 8.7] [Reference Citation Analysis]
40 Zhao Y, Yang J, Zhang L, Li Z, Yang Y, Tang Y, Fu P. Association between TNF-α -308G/A polymorphism and diabetic nephropathy risk: a meta-analysis. Int Urol Nephrol 2013;45:1653-9. [PMID: 23793620 DOI: 10.1007/s11255-013-0490-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
41 Stel VS, Awadhpersad R, Pippias M, Ferrer-Alamar M, Finne P, Fraser SD, Heaf JG, Hemmelder MH, Martínez-Castelao A, de Meester J, Palsson R, Prischl FC, Segelmark M, Traynor JP, Santamaria R, Reisaeter AV, Massy ZA, Jager KJ. International comparison of trends in patients commencing renal replacement therapy by primary renal disease. Nephrology (Carlton) 2019;24:1064-76. [PMID: 30456883 DOI: 10.1111/nep.13531] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]